NPHLA Daily
NPHLA Daily
Monday, November 9, 2026 · 3-minute read
Good morning. Here is what changed across metabolic medicine, pharmacy regulation, aesthetics and healthcare technology since yesterday — every item linked to its source.
Top development today
What changed today in AI & Technology: 1 new study
NPHLA tracked 1 new official record on this desk today: 1 new study. First: New research in JMIR rehabilitation and assistive technologies: “AI Scribe in Specialized Rehabilitation: Usability Study of Perceived Usability and Usefulness Among Physicians and Psychologists”.
Aesthetics & Longevity signal
Preparation and characterization of polydeoxyribonucleotide-poly(L-lysine) nanospheres with high penetration and hydrating properties for skin applications
From Colloids and surfaces. B, Biointerfaces.
AI & Technology signal
AI Scribe in Specialized Rehabilitation: Usability Study of Perceived Usability and Usefulness Among Physicians and Psychologists
From JMIR rehabilitation and assistive technologies.
One thing worth watching
Comments close: Compounding Animal Drugs From Bulk Drug Substances: Compounding Under CGMP in Federally-Registered Facilities; Draft Guidance for Industry; Availability; Agency Information…
November 26, 2026 — verified from the Federal Register comments_close_on.
5 things to know
- What changed today in AI & Technology: 1 new study
- AI Scribe in Specialized Rehabilitation: Usability Study of Perceived Usability and Usefulness Among Physicians and Psychologists (JMIR rehabilitation and assistive technologies)
- Preparation and characterization of polydeoxyribonucleotide-poly(L-lysine) nanospheres with high penetration and hydrating properties for skin applications (Colloids and surfaces. B, Biointerfaces)
Compiled by NPHLA Intelligence from published briefings and official records. Professional information only — not medical or legal advice. Our standards.